FDA Approves Rx to Treat Crohn's Disease in Kids
The US Food and Drug Administration (FDA) has approved a new treatment for Crohn's disease in children. It is the first treatment for pediatric Crohn's approved to be administered at home.
No Safety Surprises from Humira
Humira (adalimumab) is a medication used to treat a variety of diseases. As the medication is being prescribed to more and more patients, researchers wanted to see if there were any side effects they didn't know about before.
New Drug for Kids With Crohn's
Treatments that do exist for Crohn's disease (CD) don't always work for everyone, kids included. But a new remedy helping adults with their stomach issues may work for children. Is it safe for the little ones?
Upping the Dose in Crohn's Treatments
Easing the discomfort with Crohn's disease remains a difficult task. Though the troubles could be swayed with two medicines, the effects are temporary.
New Drug for Crohn's Patients
Maybe this is the end of long-term stomach aches and pains, at least for patients with Crohn's disease who don't respond to the common treatment.
Treating Crohn's Disease
Crohn's disease is a condition that can cause swelling and irritation in any part of the digestive tract, from the mouth all the way to the rectum. While there is no cure for Crohn's disease, there are ways to control the swelling and other symptoms.
FDA Focus on TNF Blockers
A class of drugs is now under suspicion of causing cancer in children, adolescents and young adults under the age of 30. These are called Tumor Necrosis Factor (TNF) blockers, and the U.S. Food and Drug Administration (FDA) recently released an update regarding its ongoing safety review of these drugs.
Advancing Crohn's Disease Treatment
Even 15 or 20 years ago hearing a diagnosis of Crohn's disease was bad news. Advances in treatment now mean that the disease is manageable and patients can live a normal life. It's no longer the death sentence it once was.
FDA Drug Safety Communication: TNF blockers
The U.S. Food and Drug Administration (FDA) is informing the public that it continues to receive reports of a rare cancer of white blood cells (known as h epatosplenic T-Cell lymphoma or HSTCL ), primarily in adolescents and young adults being treated for Crohn’s disease and ulcerative colitis with medicines known as tumor necrosis factor ( TNF ) blockers, as well as with azathioprine , and/or mercaptopurine . Crohn's disease and ulcerative colitis cause inflammation of the digestive system. Common symptoms are pain in the abdomen, cramps, and diarrhea. Bleeding from the rectum, wei...
Backsides and Rear Ends
Australian researchers have discovered a genetic link between a certain type of spinal arthritis and inflammatory bowel disease.